Mankind Pharma Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

2805.20

-85.85 (-2.97%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

2805.20

-85.85 (-2.97%)
16:02 Dec 20

Quality

89/100
High Financial Strength

Valuation

22/100
Expensive Valuation

Technical

66/100
Technically Moderately Bullish

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM 2024
Net Sales	6214.43	7781.56	8749.43	10334.77	11017.99
Operating Expenses +	4566.33	5792.2	6848.79	7799.71	8288.57
Raw Material	2028	2871.31	2622.9	3263.37	3380.4
Increase Decrease in Cost	-247.4	-449.59	290.74	-53.67	-128.11
Other Manufacturing Expense	0	0	0	0	0
Employee Cost	1415.78	1620.59	1918.47	2274.73	2430.07
Miscellaneous Expenses	2679.59	3377.39	3635.16	5134.98	2606.21
Operating Profit	1648.1	1989.36	1900.64	2535.06	2729.42
Other Income	170.95	196.03	128.57	280.86	372.29
Depreciation	118.97	166.62	325.92	398.25	427.78
Interest	20.15	58.61	44.47	33.53	36.58
Profit before tax and exceptio..	1679.93	1960.15	1658.81	2384.14	2637.35
Exceptional Items	0	0	0	0	0
PBT	1679.93	1960.15	1658.81	2384.14	2637.35
Provision for Taxation	398.58	521.64	361.56	457.59	512.49
Net Profit	1281.36	1438.51	1297.25	1926.56	2124.86
NET Profit after MI	1265.43	1433.48	1281.86	1912.9	2114.96
EPS	31.59	35.78	32	47.68	52.79
Operating Profit Margin (%)	26.52	25.57	21.72	24.53	24.77
Net Profit Margin (%)	20.36	18.42	14.65	18.51	19.2

ShareHolding

All Data in Percentage (%)

	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23
Promoter	74.90	74.90	74.90	76.50	76.50
FII	12.40	11.60	9.90	6.70	4.20
MF	7.00	7.40	8.60	7.60	3.90
Public	2.90	3.60	4.10	7.00	14.80
Others	0.00	0.00	0.00	0.00	0.00
Others	2.80	2.50	2.50	2.20	0.60